LB Pharmaceuticals SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

4Oct. 13, 2026, 4:10 p.m. ETView on SEC.gov
4Oct. 13, 2026, 4:10 p.m. ETView on SEC.gov
SCHEDULE 13G/AOct. 13, 2026, 1:46 p.m. ETView on SEC.gov
8-KSept. 15, 2026, 8:05 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
8-KSept. 3, 2026, 8:05 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
SCHEDULE 13G/AAug. 14, 2026, 4:18 p.m. ETView on SEC.gov
10-QAug. 11, 2026, 8:10 a.m. ETView on SEC.gov
8-KAug. 11, 2026, 8:05 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
4Aug. 3, 2026, 7:28 p.m. ETView on SEC.gov
SCHEDULE 13G/AJuly 29, 2026, 3:19 p.m. ETView on SEC.gov
8-KJuly 29, 2026, 8:05 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits